In recent years, there are increasing interests in the treatment of obesity by targeting GLP-1 signaling (DeFronzo et al., 2005; Astrup et al., 2009; Shah and Vella, 2014; Ladenheim, 2015; Isaacs et al., 2016). This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.